⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
NVS News
Novartis AG
Novartis IgAN data in New England Journal of Medicine show Fabhalta® slowed kidney function decline by 49.3%
globenewswire.com
NVS
Институт Critical Path Institute запускает программу One to Millions, чтобы изменить будущее персонализированной медицины в глобальном масштабе USA - Pусский USA - English USA - English USA - Français USA - slovenčina USA - Polski USA - español USA -
prnewswire.com
BMY
MRK
PFE
GILD
REGN
AZN
NVS
BIIB
ALKS
CRIS
EDIT
NTLA
Pelvic Cancer Induced Hemorrhagic Cystitis Market Poised for Very Strong Growth: Expected to Reach $7.98 Billion by 2030
globenewswire.com
PFE
JNJ
MRK
ABBV
SNY
BMY
AZN
NVS
AMGN
Vulvar Cancer Market Size to Grow by $270 Million During 2026-2030: Investments and Personalized Medicine Drive Market Expansion
globenewswire.com
MRK
BMY
NVS
CAR T-Cell Therapy Market to Hit USD 13.78 Billion by 2031, Driven by Rising Global Cancer Prevalence - Insights by Product, Target, Indication, Demographic, Region, and Competitive Landscape
globenewswire.com
BIIB
GILD
BMY
NVS
MRK
Excellergy to be acquired by Novartis for up to USD 2 billion to advance potentially first-in-class trifunctional effector cell response inhibitors
globenewswire.com
NVS
Novartis agrees to acquire Excellergy, Inc., building on allergy leadership with next-generation anti-IgE innovation
globenewswire.com
NVS
Neuroprotective Agents Market to Reach $60.9 Billion by 2030 as Neurological Disease Burden and Aging Populations Drive Pharmaceutical Investment
globenewswire.com
ABBV
AZN
BIIB
BMY
GSK
LLY
MRK
NVS
SNY
TEVA
UCB
Inveniam Hires Former Bloomberg and Moody's Leader to Meet Rising Institutional Demand for AI-Ready Data
prnewswire.com
IBM
MUFG
MS
GS
JPM
BAC
WFC
SCHW
AMTD
AXP
V
MA
PYPL
COF
SYK
BMY
PFE
MRK
JNJ
UNH
CVS
CI
AMGN
GILD
BIIB
REGN
AZN
NVS
TSM
NVDA
INTC
AMD
QCOM
AMAT
LRCX
MU
ADBE
CRM
GOOG
GOOGL
AMZN
MSFT
AAPL
META
NFLX
CMCSA
T
VZ
DIS
HD
MCD
SBUX
KO
PEP
CAT
BA
GE
XOM
CVX
HSBC
BCS
NYT
BKR
HAL
SLB
COP
EOG
APA
OXY
DVN
BioAge Labs Reports Full Year 2025 Financial Results and Provides Business Updates from the Fourth Quarter of 2025
globenewswire.com
NVS